188 related articles for article (PubMed ID: 33053220)
1. Anti-Interleukin-6 Therapy Decreases Hip Synovitis and Bone Resorption and Increases Bone Formation Following Ischemic Osteonecrosis of the Femoral Head.
Ren Y; Deng Z; Gokani V; Kutschke M; Mitchell TW; Aruwajoye O; Adapala NS; Kamiya N; Abu-Amer Y; Kim HK
J Bone Miner Res; 2021 Feb; 36(2):357-368. PubMed ID: 33053220
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model.
Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW
Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727
[TBL] [Abstract][Full Text] [Related]
3. Legg-Calvé-Perthes disease produces chronic hip synovitis and elevation of interleukin-6 in the synovial fluid.
Kamiya N; Yamaguchi R; Adapala NS; Chen E; Neal D; Jack O; Thoveson A; Gudmundsson P; Brabham C; Aruwajoye O; Drissi H; Kim HK
J Bone Miner Res; 2015 Jun; 30(6):1009-13. PubMed ID: 25556551
[TBL] [Abstract][Full Text] [Related]
4. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
Kim HK; Morgan-Bagley S; Kostenuik P
J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Transphyseal Neck-Head Tunneling and Multiple Epiphyseal Drilling on Femoral Head Healing Following Ischemic Osteonecrosis: An Experimental Investigation in Immature Pigs.
Aruwajoye OO; Monte F; Kim A; Kim HKW
J Pediatr Orthop; 2020 Apr; 40(4):168-175. PubMed ID: 32132446
[TBL] [Abstract][Full Text] [Related]
6. Local administration of bone morphogenetic protein-2 and bisphosphonate during non-weight-bearing treatment of ischemic osteonecrosis of the femoral head: an experimental investigation in immature pigs.
Kim HK; Aruwajoye O; Du J; Kamiya N
J Bone Joint Surg Am; 2014 Sep; 96(18):1515-24. PubMed ID: 25232075
[TBL] [Abstract][Full Text] [Related]
7. Damage associated molecular patterns in necrotic femoral head inhibit osteogenesis and promote fibrogenesis of mesenchymal stem cells.
Deng Z; Ren Y; Park MS; Kim HKW
Bone; 2022 Jan; 154():116215. PubMed ID: 34571205
[TBL] [Abstract][Full Text] [Related]
8. HIF-1-Dependent IL-6 Activation in Articular Chondrocytes Initiating Synovitis in Femoral Head Ischemic Osteonecrosis.
Yamaguchi R; Kamiya N; Adapala NS; Drissi H; Kim HK
J Bone Joint Surg Am; 2016 Jul; 98(13):1122-31. PubMed ID: 27385686
[TBL] [Abstract][Full Text] [Related]
9. IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice.
Kamiya N; Kuroyanagi G; Aruwajoye O; Kim HKW
Osteoarthritis Cartilage; 2019 Feb; 27(2):326-335. PubMed ID: 30404032
[TBL] [Abstract][Full Text] [Related]
10. Ischemic femoral head osteonecrosis in a piglet model causes three dimensional decrease in acetabular coverage.
Upasani VV; Jeffords ME; Farnsworth CL; Padilla D; Lopreiato N; Aruwajoye OO; Kim HKW
J Orthop Res; 2018 Apr; 36(4):1173-1177. PubMed ID: 28914956
[TBL] [Abstract][Full Text] [Related]
11. Elevation of Proinflammatory Cytokine HMGB1 in the Synovial Fluid of Patients With Legg-Calvé-Perthes Disease and Correlation With IL-6.
Kamiya N; Kim HK
JBMR Plus; 2021 Feb; 5(2):e10429. PubMed ID: 33615102
[TBL] [Abstract][Full Text] [Related]
12. Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease.
Young ML; Little DG; Kim HK
Clin Orthop Relat Res; 2012 Sep; 470(9):2462-75. PubMed ID: 22270467
[TBL] [Abstract][Full Text] [Related]
13. Intravoxel incoherent motion (IVIM) detects femoral head ischemia in a piglet model of Legg-Calvé-Perthes disease.
Buko EO; Bhave S; Moeller S; Laine JC; Tóth F; Johnson CP
J Orthop Res; 2024 Apr; 42(4):855-863. PubMed ID: 37971281
[TBL] [Abstract][Full Text] [Related]
14. 3D MRI Quantification of Femoral Head Deformity in Legg-Calvé-Perthes Disease.
Standefer KD; Dempsey M; Jo C; Kim HKW
J Orthop Res; 2017 Sep; 35(9):2051-2058. PubMed ID: 27864891
[TBL] [Abstract][Full Text] [Related]
15. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
Little DG; Kim HK
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
[TBL] [Abstract][Full Text] [Related]
16. Minimally Invasive Necrotic Bone Washing Improves Bone Healing After Femoral Head Ischemic Osteonecrosis: An Experimental Investigation in Immature Pigs.
Kim HKW; Park MS; Alves do Monte F; Gokani V; Aruwajoye OO; Ren Y
J Bone Joint Surg Am; 2021 Jul; 103(13):1193-1202. PubMed ID: 33877059
[TBL] [Abstract][Full Text] [Related]
17. Quantitative susceptibility mapping detects neovascularization of the epiphyseal cartilage after ischemic injury in a piglet model of legg-calvé-perthes disease.
Johnson CP; Wang L; Tóth F; Aruwajoye O; Kirkham B; Carlson CS; Kim HKW; Ellermann JM
J Magn Reson Imaging; 2019 Jul; 50(1):106-113. PubMed ID: 30556613
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonography in Legg-Calvé-Perthes disease.
Wirth T; LeQuesne GW; Paterson DC
Pediatr Radiol; 1992; 22(7):498-504. PubMed ID: 1491906
[TBL] [Abstract][Full Text] [Related]
19. Biomechanical properties of bone and cartilage in growing femoral head following ischemic osteonecrosis.
Koob TJ; Pringle D; Gedbaw E; Meredith J; Berrios R; Kim HK
J Orthop Res; 2007 Jun; 25(6):750-7. PubMed ID: 17318897
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and new strategies for the treatment of Legg-Calvé-Perthes disease.
Kim HK
J Bone Joint Surg Am; 2012 Apr; 94(7):659-69. PubMed ID: 22488623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
